Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Anti-Infective Peptides Competitor Analysis
Publication Date Dec 2011
Publisher La Merie Publishing
Product Type Report
Pages 44
Single User License help $ 376.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Anti-Viral Peptides

Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).

Anti-Bacterial Peptides

Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.

Anti-Fungal Peptides

Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more

The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

  • Anti-Bacterial Peptides
  • Anti-Viral Peptides
  • Anti-Fungal Peptides
  • Corporate Anti-Infective Peptide R&D Pipelines

Title Date Price
Alzheimer's Disease Partnering 2007-2012
By CurrentPartnering
The Alzheimer's Disease Partnering 2007-2012 provides understanding and access to the alzheimer's disease partnering deals and agreements entered into by the worlds leading healthcare companies . Th ...Read More
May 2012 $998.00
Alzheimer's Disease Partnering 2007-2013
By CurrentPartnering
The Alzheimer's Disease Partnering 2007-2013 report provides understanding and access to the alzheimer's disease partnering deals and agreements entered into by the worlds leading healthcare companies ...Read More
Jan 2013 $1795.00
Angina Partnering 2007-2012
By CurrentPartnering
Angina Partnering 2007-2012 provides understanding and access to the angina partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of ...Read More
May 2012 $998.00
Anti-Infective Peptides Competitor Analysis
By La Merie Publishing
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with an ...Read More
Dec 2011 $376.00
Anti-Obesity Biologics Competitor Analysis
By La Merie Publishing
Product description The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of ...Read More
Feb 2012 $251.00
Antibiotics Partnering Terms and Agreements
By CurrentPartnering
The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   Tre ...Read More
Jun 2014 $1995.00
Antibody Partnering Terms and Agreements
By CurrentPartnering
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading hea ...Read More
Mar 2012 $2694.00
Antibody-Drug Conjugates (ADC) Competitor Analysis
By La Merie Publishing
The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated with a drug p ...Read More
Dec 2011 $627.00
Anxiety Partnering 2007-2012
By CurrentPartnering
The Anxiety Partnering 2007-2012 provides understanding and access to the anxiety partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an anal ...Read More
May 2012 $998.00
Arrhythmia Partnering 2007-2012
By CurrentPartnering
Arrhythmia Partnering 2007-2012 provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an ana ...Read More
May 2012 $998.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   
   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z